Elanco CFO granted deferred stock units

Elanco Animal Health executive vice president and CFO Robert M. VanHimbergen reported a compensation-related grant of deferred stock units.

Rhea-AI Filing Summary

Elanco Animal Health executive vice president and CFO Robert M. VanHimbergen reported a compensation-related grant of deferred stock units. He acquired 9.485 deferred stock units tied to Company common stock, bringing his direct holding in this award type to 40.5769 units. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent, settling in cash or shares after employment ends or in a specified future year under the Executive Deferral and Stock Match Plan.

Insider Trade Summary

Grant/Award: 9.485 shares

Grant/Award 1 txn

Insider VanHimbergen Robert M

Role EVP and CFO

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	9.485	$23.36	$221.57

Holdings After Transaction: Deferred Stock Units — 40.5769 contracts (Direct)

Footnotes (2)

1. F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Elanco (ELAN) report for CFO Robert M. VanHimbergen?

Elanco reported that CFO Robert M. VanHimbergen received a grant of deferred stock units. The award is a form of compensation linked to Company common stock and is not an open-market stock purchase or sale.

How many deferred stock units did the Elanco CFO receive in this Form 4?

The Elanco CFO received 9.485 deferred stock units in this transaction. These units are tied to Company common stock and increase his direct holding of this type of award to a total of 40.5769 deferred stock units.

What are deferred stock units in Elanco (ELAN) executive compensation?

Deferred stock units are compensation awards that track Company common stock. Each unit gives the right to receive one share of Elanco common stock or the cash equivalent, according to the terms of the Executive Deferral and Stock Match Plan.

When will the Elanco CFO’s deferred stock units reported on Form 4 be settled?

The deferred stock units will be settled in cash or shares after employment ends or during a specified future year. Settlement timing follows the choices and rules in Elanco’s Executive Deferral and Stock Match Plan, rather than occurring immediately.

Does this Elanco Form 4 show the CFO buying or selling ELAN shares on the market?

No, the Form 4 shows a grant of deferred stock units as compensation, not an open-market trade. The units represent a right to future stock or cash rather than an immediate purchase or sale of ELAN common shares.

How many total deferred stock units does the Elanco CFO hold after this grant?

After this grant, the Elanco CFO directly holds 40.5769 deferred stock units. Each unit corresponds to one share of Company common stock or its cash equivalent, to be settled at a future date under the plan’s terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/10/2026 - 04:14 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VanHimbergen Robert M

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS IN 46221

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and CFO

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	03/06/2026		A		9.485		(2)	(2)	Common Stock	9.485	$23.36	40.5769	D

Explanation of Responses:

1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Robert M. VanHimbergen	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.